Filter
288
Filtered Results: 288
Text search:
pharma
company
Featured
Recommendations
12
New Publications
77
Language
Document type
No document type
152
Studies & Reports
71
Guidelines
31
Manuals
12
Strategic & Response Plan
11
Fact sheets
4
Training Material
3
Situation Updates
3
Resource Platforms
1
Countries / Regions
South Africa
14
India
14
Kenya
13
Global
12
Zimbabwe
11
Ethiopia
11
Ghana
8
Tanzania
8
Uganda
8
Nepal
7
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Philippines
6
Bangladesh
5
Namibia
5
Botswana
5
Zambia
5
Rwanda
4
Eastern Europe and Central Asia
4
Ukraine
3
Liberia
3
Myanmar / Burma
3
Lesotho
2
Benin
2
Senegal
2
Burkina Faso
2
Mongolia
2
Haiti
2
Latin America and the Carribbean
2
Eastern Europe
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
Thailand
1
Serbia
1
China
1
Kazakhstan
1
Syria
1
Kyrgyzstan
1
Uzbekistan
1
Malaysia
1
Mozambique
1
Armenia
1
Cambodia
1
Germany
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Argentina
1
Papua New Guinea
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Indonesia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
20
Public Health
12
Women & Child Health
10
Pharmacy & Technologies
10
Key Resources
2
Toolboxes
Pharmacy
36
AMR
28
HIV
15
COVID-19
12
TB
10
NCDs
10
Mental Health
8
Caregiver
5
Planetary Health
4
Global Health Education
4
NTDs
3
Rapid Response
2
Refugee
2
Disability
2
Health Financing Toolbox
2
Specific Hazards
1
Conflict
1
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Recommended actions and international and national level
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Procedures Manual - Medicines registration in Madagascar - 2016 version
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
Recommended actions at international and national levels
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
The procurement of essential medicines and other health products is a critical function in support of the effective discharge of WHO’s mandate, and WHO values the importance of the quality of essential medicines and health products that are supplied to countries. The first World Health Assembly in...
